Progressive Care to Report First Quarter Financial Results on May 17, 2022
May 13 2022 - 8:06AM
InvestorsHub NewsWire
Progressive Care Inc. Has
Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday,
May 17, 2022
MIAMI, FL -- May 13, 2022 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD), a personalized healthcare services and technology
company (the “Company” or “Progressive Care”), is pleased to
announce that the Company has scheduled an investor conference call
for 4:30 PM ET on Tuesday, May 17, 2022.
See on website
Chairman and CEO, Alan Jay Weisberg, stated, “We are looking
forward to providing our shareholders with our first quarter
results, Company’s vision for the rest of 2022, and an update
regarding our progress towards uplisting to Nasdaq.”
Those attending the investor conference call will have the
opportunity to submit questions concerning the Company in advance
to Stuart Smith of SmallCapVoice.Com, Inc. via
e-mail: ssmith@smallcapvoice.com by
12:00 PM EST on Monday, May 16, 2022. The Company plans to address
as many appropriate questions as possible.
To access the call:
Dial-In Number: 1-857-232-0157
Access Code: 422095
For those unable to participate in the live conference call, a
replay will be available at https://www.smallcapvoice.com/clients/rxmd/. shortly
after the call has concluded.
An archived version of the webcast will also be
available https://progressivecareus.com/news/.
Progressive Care Inc.
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
PharmCoRx
https://www.pharmcorx.com/
ClearMetrX
https://www.clearmetrx.com/
Forward-Looking Statements:
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Such forward-looking statements
reflect the Company’s expectations about its future operating
results, performance, and opportunities that involve substantial
risks and uncertainties. When used herein, the words “anticipate,”
“believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and
“expect” and similar expressions, as they relate to Progressive
Care Inc., its subsidiaries, or its management, are intended to
identify such forward-looking statements. These forward-looking
statements are based on information currently available to the
Company and are subject to a number of risks, uncertainties, and
other factors that could cause the Company’s actual results,
performance, prospects, and opportunities to differ materially from
those expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024